On Monday, Agenus Inc (NASDAQ: AGEN) opened lower -5.94% from the last session, before settling in for the closing price of $1.60. Price fluctuations for AGEN have ranged from $1.55 to $19.69 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 30.58% over the past five years. Company’s average yearly earnings per share was noted 57.70% at the time writing. With a float of $24.67 million, this company’s outstanding shares have now reached $25.31 million.
Let’s look at the performance matrix of the company that is accounted for 316 employees. In terms of profitability, gross margin is 23.94%, operating margin of -116.44%, and the pretax margin is -223.75%.
Agenus Inc (AGEN) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Agenus Inc is 2.51%, while institutional ownership is 32.55%.
Agenus Inc (AGEN) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.25 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 57.70% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 39.34% during the next five years compared to 7.90% growth over the previous five years of trading.
Agenus Inc (NASDAQ: AGEN) Trading Performance Indicators
Check out the current performance indicators for Agenus Inc (AGEN). In the past quarter, the stock posted a quick ratio of 0.21. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.37.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -10.69, a number that is poised to hit -1.60 in the next quarter and is forecasted to reach -2.94 in one year’s time.
Technical Analysis of Agenus Inc (AGEN)
Agenus Inc (NASDAQ: AGEN) saw its 5-day average volume 0.45 million, a positive change from its year-to-date volume of 0.43 million. As of the previous 9 days, the stock’s Stochastic %D was 22.73%. Additionally, its Average True Range was 0.18.
During the past 100 days, Agenus Inc’s (AGEN) raw stochastic average was set at 2.18%, which indicates a significant decrease from 9.85% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 79.02% in the past 14 days, which was lower than the 92.99% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.8085, while its 200-day Moving Average is $5.3385. Nevertheless, the first resistance level for the watch stands at $1.5700 in the near term. At $1.6350, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.7000. If the price goes on to break the first support level at $1.4400, it is likely to go to the next support level at $1.3750. Assuming the price breaks the second support level, the third support level stands at $1.3100.
Agenus Inc (NASDAQ: AGEN) Key Stats
There are currently 25,309K shares outstanding in the company with a market cap of 38.09 million. Presently, the company’s annual sales total 103,460 K according to its annual income of -227,210 K. Last quarter, the company’s sales amounted to 26,840 K and its income totaled -45,860 K.